A Phase II, Double-Blinded, Placebo Controlled Randomized Trial of Salvage Radiotherapy With or Without Enhanced Anti-androgen Therapy With Apalutamide in Recurrent Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 18 Feb 2019
At a glance
- Drugs Apalutamide (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 27 Apr 2018 Status changed from not yet recruiting to recruiting.
- 23 Apr 2018 Planned initiation date changed from 13 Apr 2018 to 27 Apr 2018.